Publication list
2024
Tóth, K.,
Ádám, D.,
Arany, J.,
Ramirez, Y.,
Bíró, T.,
Drake, J.,
O'Mahony, A.,
Szöllősi, A.,
Póliska, S.,
Kilic, A.,
Soeberdt, M.,
Abels, C.,
Oláh, A.:
Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes and suppresses their endothelin release.
Exp. Dermatol. 33 (1), 1-15, 2024.
Journal metrics:
Q2 Biochemistry (2022)
Q1 Dermatology (2022)
Q2 Molecular Biology (2022)
2023
Arany, J.,
Ádám, D.,
Cseszlai, M.,
Nyitrai, T.,
Zouboulis, C.,
Oláh, A.:
Adenosine receptors are novel regulators of human sebocyte biology.
J. Invest. Dermatol. 143 (Suppl_11), S355, 2023.
Tóth, K.,
Ádám, D.,
Arany, J.,
Ramirez, Y.,
Bíró, T.,
Drake, J.,
O'Mahony, A.,
Szöllősi, A.,
Kilic, A.,
Soeberdt, M.,
Abels, C.,
Oláh, A.:
Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes, and suppresses endothelin release via inhibiting PI3K.
J. Invest. Dermatol. 143 (5), S126, 2023.
Tóth, K.,
Ádám, D.,
Arany, J.,
Ramirez, Y.,
Bíró, T.,
Drake, J.,
O'Mahony, A.,
Szöllősi, A.,
Kilic, A.,
Soeberdt, M.,
Abels, C.,
Oláh, A.:
Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes, and suppresses their endothelin release.
J. Invest. Dermatol. 143 (11), S361, 2023.
Lőrincz, E.,
Tóth, G.,
Spolárics, J.,
Herczeg, M.,
Hodek, J.,
Zupkó, I.,
Minorics, R.,
Ádám, D.,
Oláh, A.,
Zouboulis, C.,
Weber, J.,
Nagy, L.,
Ostorházi, E.,
Bácskay, I.,
Borbás, A.,
Herczegh, P.,
Bereczki, I.:
Mannich-type modifications of (-)-cannabidiol and (-)-cannabigerol leading to new, bioactive derivatives.
Sci. Rep. 13 (1), 19618, 2023.
Journal metrics:
D1 Multidisciplinary (2022)
Ádám, D.,
Arany, J.,
Pető, O.,
Tóth, I.,
Zouboulis, C.,
Oláh, A.:
The TRPM5 antagonist TPPO increases sebaceous lipogenesis and exerts pro-inflammatory effects via activation of Akt and p38 MAPK cascades.
J. Invest. Dermatol. 143 (11), S354, 2023.
2022
Ádám, D.,
Arany, J.,
Tóth, K.,
Tóth, I.,
Szöllősi, A.,
Oláh, A.:
Opioidergic Signaling: a Neglected, Yet Potentially Important Player in Atopic Dermatitis.
Int. J. Mol. Sci. 23 (8), 4140, 2022.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2020
Markovics, A.,
Angyal, Á.,
Tóth, K.,
Ádám, D.,
Pénzes, Z.,
Magi, J.,
Pór, Á.,
Kovács, I.,
Töröcsik, D.,
Zouboulis, C.,
Bíró, T.,
Oláh, A.:
GPR119 is a potent regulator of human sebocyte biology.
J. Invest. Dermatol. 140 (10), 1909-1918, 2020.
Journal metrics:
Q1 Biochemistry
Q1 Cell Biology
D1 Dermatology
Q1 Molecular Biology
2019
Tóth, K.,
Ádám, D.,
Arany, J.,
Faragó, P.,
Arbiser, J.,
Zouboulis, C.,
Bíró, T.,
Oláh, A.:
The putative tribbles homolog 3 (TRIB3) activator honokiol suppresses lipogenesis, and exerts anti-proliferative as well as anti-inflammatory effects on human sebocytes.
J. Invest. Dermatol. 139 (9S), S319, 2019.
2018
Ádám, D.,
Tóth, K.,
Sárkány, F.,
Soeberdt, M.,
Abels, C.,
Oláh, A.,
Bíró, T.:
Activation of k-opioid receptor (KOR) suppresses pro-inflammatory response of human epidermal keratinocytes.
Exp. Dermatol. 27 (Suppl.), 38, 2018.
Tóth, K.,
Markovics, A.,
Ádám, D.,
Pénzes, Z.,
Angyal, Á.,
Magi, J.,
Pór, Á.,
Kovács, I.,
Zouboulis, C.,
Bíró, T.,
Oláh, A.:
GPR119 is a potent novel regulator of human sebocyte biology.
Exp. Dermatol. 27 (Suppl.), 36-37, 2018.
updated: 2024-04-21, 02:00
